Chemical Component Summary

Formula C H5 N3
Molecular Weight 59.07 g/mol
Type non-polymer
Isomeric SMILES NC(N)=N
InChI InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4)

Chemical Details

Formal Charge 0
Atom Count 9
Chiral Atom Count 0
Chiral Atoms
Bond Count 8
Aromatic Bond Count 0

Drug Info: DrugBank

DrugBank ID DB00536   (Stereoisomeric match)
Name Guanidine
Groups approved
Description A strong organic base existing primarily as guanidium ions at physiological pH. It is found in the urine as a normal product of protein metabolism. It is also used in laboratory research as a protein denaturant. (From Martindale, the Extra Pharmacopoeia, 30th ed and Merck Index, 12th ed) It is also used in the treatment of myasthenia and as a fluorescent probe in HPLC. [PubChem]
  • Aminomethanamidine
  • Gu
  • Guanidin
  • H2N-C(=NH)-NH2
Salts Guanidine hydrochloride
Brand Names Guanidine Hydrochloride
Affected Organism Humans and other mammals
Indication For the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of Eaton-Lambert. It is not indicated for treating myasthenia gravis.
Pharmacology Guanidine apparently acts by enhancing the release of acetylcholine following a nerve impulse. It also appears to slow the rates of depolarization and repolarization of muscle cell membranes.
Route of administration Oral
  • Amidines
  • Guanidines
  • Organic Chemicals
CAS number 113-00-8
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682